Israel · Delayed Price · Currency is ILS · Price in ILA Ilex Medical Statistics
Total Valuation
Ilex Medical has a market cap or net worth of ILS 729.58 million. The enterprise value is 522.59 million.
| Market Cap | 729.58M |
| Enterprise Value | 522.59M |
Important Dates
The next estimated earnings date is Tuesday, November 25, 2025.
| Earnings Date | Nov 25, 2025 |
| Ex-Dividend Date | Apr 7, 2025 |
Share Statistics
Ilex Medical has 11.19 million shares outstanding. The number of shares has decreased by -0.43% in one year.
| Current Share Class | 11.19M |
| Shares Outstanding | 11.19M |
| Shares Change (YoY) | -0.43% |
| Shares Change (QoQ) | -0.36% |
| Owned by Insiders (%) | 62.77% |
| Owned by Institutions (%) | 12.97% |
| Float | 2.84M |
Valuation Ratios
The trailing PE ratio is 14.42.
| PE Ratio | 14.42 |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | 22.38 |
| P/OCF Ratio | 12.38 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.20, with an EV/FCF ratio of 16.03.
| EV / Earnings | 11.46 |
| EV / Sales | 0.56 |
| EV / EBITDA | 5.20 |
| EV / EBIT | 9.90 |
| EV / FCF | 16.03 |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.09 |
| Quick Ratio | 2.30 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.43 |
| Debt / FCF | 1.43 |
| Interest Coverage | 24.84 |
Financial Efficiency
Return on equity (ROE) is 7.84% and return on invested capital (ROIC) is 5.50%.
| Return on Equity (ROE) | 7.84% |
| Return on Assets (ROA) | 3.93% |
| Return on Invested Capital (ROIC) | 5.50% |
| Return on Capital Employed (ROCE) | 8.39% |
| Revenue Per Employee | 5.21M |
| Profits Per Employee | 256,213 |
| Employee Count | 178 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 4.45 |
Taxes
In the past 12 months, Ilex Medical has paid 18.71 million in taxes.
| Income Tax | 18.71M |
| Effective Tax Rate | 27.03% |
Stock Price Statistics
The stock price has increased by +3.54% in the last 52 weeks. The beta is -0.08, so Ilex Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | +3.54% |
| 50-Day Moving Average | 6,276.98 |
| 200-Day Moving Average | 6,500.12 |
| Relative Strength Index (RSI) | 55.88 |
| Average Volume (20 Days) | 1,555 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ilex Medical had revenue of ILS 927.57 million and earned 45.61 million in profits. Earnings per share was 4.08.
| Revenue | 927.57M |
| Gross Profit | 216.01M |
| Operating Income | 61.11M |
| Pretax Income | 69.22M |
| Net Income | 45.61M |
| EBITDA | 95.22M |
| EBIT | 61.11M |
| Earnings Per Share (EPS) | 4.08 |
Balance Sheet
The company has 253.70 million in cash and 46.72 million in debt, giving a net cash position of 206.99 million or 18.50 per share.
| Cash & Cash Equivalents | 253.70M |
| Total Debt | 46.72M |
| Net Cash | 206.99M |
| Net Cash Per Share | 18.50 |
| Equity (Book Value) | 660.36M |
| Book Value Per Share | 58.92 |
| Working Capital | 456.84M |
Cash Flow
In the last 12 months, operating cash flow was 58.91 million and capital expenditures -26.31 million, giving a free cash flow of 32.60 million.
| Operating Cash Flow | 58.91M |
| Capital Expenditures | -26.31M |
| Free Cash Flow | 32.60M |
| FCF Per Share | 2.91 |
Margins
Gross margin is 23.29%, with operating and profit margins of 6.59% and 4.92%.
| Gross Margin | 23.29% |
| Operating Margin | 6.59% |
| Pretax Margin | 7.46% |
| Profit Margin | 4.92% |
| EBITDA Margin | 10.27% |
| EBIT Margin | 6.59% |
| FCF Margin | 3.51% |
Dividends & Yields
This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 1.87%.
| Dividend Per Share | 1.22 |
| Dividend Yield | 1.87% |
| Dividend Growth (YoY) | -10.63% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 29.91% |
| Buyback Yield | 0.43% |
| Shareholder Yield | 2.30% |
| Earnings Yield | 6.25% |
| FCF Yield | 4.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.
| Last Split Date | Aug 21, 2000 |
| Split Type | Forward |
| Split Ratio | 9 |
Scores
Ilex Medical has an Altman Z-Score of 4.21 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.21 |
| Piotroski F-Score | 5 |